Agios Pharmaceuticals (AGIO) Non Operating Income (2021 - 2025)
Historic Non Operating Income for Agios Pharmaceuticals (AGIO) over the last 5 years, with Q4 2025 value amounting to $113000.0.
- Agios Pharmaceuticals' Non Operating Income fell 9303.76% to $113000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $2.0 million, marking a year-over-year decrease of 6984.74%. This contributed to the annual value of $2.0 million for FY2025, which is 6984.74% down from last year.
- Latest data reveals that Agios Pharmaceuticals reported Non Operating Income of $113000.0 as of Q4 2025, which was down 9303.76% from $67000.0 recorded in Q3 2025.
- Over the past 5 years, Agios Pharmaceuticals' Non Operating Income peaked at $6.5 million during Q2 2021, and registered a low of $67000.0 during Q3 2025.
- Over the past 5 years, Agios Pharmaceuticals' median Non Operating Income value was $1.6 million (recorded in 2024), while the average stood at $1.9 million.
- Per our database at Business Quant, Agios Pharmaceuticals' Non Operating Income soared by 3781.3% in 2024 and then tumbled by 9594.19% in 2025.
- Agios Pharmaceuticals' Non Operating Income (Quarter) stood at $3.3 million in 2021, then crashed by 58.48% to $1.4 million in 2022, then rose by 26.23% to $1.7 million in 2023, then decreased by 5.25% to $1.6 million in 2024, then tumbled by 93.04% to $113000.0 in 2025.
- Its Non Operating Income was $113000.0 in Q4 2025, compared to $67000.0 in Q3 2025 and $523000.0 in Q2 2025.